Lihui Wei

Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial

You‐Lin Qiao, Ting Wu, Rongcheng Li et al. · JNCI Journal of the National Cancer Institute · 2019 · 172 citations · Full text

Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China

Junji Zhang, Yuqian Zhao, Yi Dai et al. · JAMA Oncology · 2020 · 123 citations · Full text

Calcium and TRPV4 promote metastasis by regulating cytoskeleton through the RhoA/ROCK1 pathway in endometrial cancer

Xingchen Li, Yuan Cheng, Zhiqi Wang et al. · Cell Death and Disease · 2020 · 115 citations · Full text

Signal Transduction, Signaling Pathway, Medicine +13

Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial

Fanghui Zhao, Ting Wu, Yuemei Hu et al. · The Lancet Infectious Diseases · 2022 · 85 citations

Vaccination, Vaccine Safety, L1 Virus-like-particle Vaccine +11

Genotype B and Younger Patient Age Associated with Better Response to Low-Dose Therapy: A Trial with Pegylated/Nonpegylated Interferon- -2b for Hepatitis B e Antigen--Positive Patients with Chronic Hepatitis B in China

Hong Zhao, Fuat Kurbanov, M.-B. Wan et al. · Clinical Infectious Diseases · 2007 · 77 citations · Full text